Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Dow
Johnson and Johnson
Teva
Harvard Business School
Boehringer Ingelheim
QuintilesIMS
Medtronic
Daiichi Sankyo

Generated: November 20, 2018

DrugPatentWatch Database Preview

Piroxicam - Generic Drug Details

« Back to Dashboard

What are the generic sources for piroxicam and what is the scope of piroxicam freedom to operate?

Piroxicam is the generic ingredient in two branded drugs marketed by Pfizer, Breckenridge Pharm, Cycle Pharms Ltd, Egis, Flamingo Pharms, Hikma Pharms, Ivax Sub Teva Pharms, Micro Labs, Mylan, Mylan Ireland Ltd, PII, SCS, Strides Pharma, Sun Pharm Industries, Teva, Teva Pharms, Unichem Labs Ltd, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for piroxicam. Twenty-four suppliers are listed for this compound.

Pharmacology for piroxicam
Medical Subject Heading (MeSH) Categories for piroxicam
Synonyms for piroxicam
(3E)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1
(3Z)-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1
(4-hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamid e
(4-Hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamide
(E)-3-(hydroxy(pyridin-2-ylamino)methylene)-2-methyl-2,3-dihydro-4H-benzo[e][1,2]thiazin-4-one 1,1-dioxide
(Z)-3-(hydroxy(pyridin-2-ylamino)methylene)-2-methyl-2H-benzo[e][1,2]thiazin-4(3H)-one 1,1-dioxide
1044566-76-8
13T4O6VMAM
1488516-58-0
2-methyl-N-(pyridin-2-yl)-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide
2H-1,2-Benzothiazine-3-carboxamide,4-hydroxy-2-methyl-N-2-pyridinyl-,1,1-dioxide
3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxo-1
3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-2,3-dihydro-4h-1,2-benzothiazin-4-one 1,1-dioxide
3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-3,4-dihydro-2H-1
3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-3,4-dihydro-2H-1$l^{6},2-benzothiazine-1,1,4-trione
3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda,2-benzothiazine-1,1,4-trione
3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trione
3,4-Dihydro-2-methyl-4-oxo-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
322P904
36322-90-4
4-?HYDROXY-?2-?METHYL-?N-?2-?PYRIDINYL-?2H-?1,?2-?BENZOTHIAZINE-?3-?CARBOXAMIDE-?1,?1-?DIOXIDE
4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1,2-dihydro-1lambda,2-benzothiazine-3-carboxamide
4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1$l^{6},2-benzothiazine-3-carboxamide
4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1$l;{6},2-benzothiazine-3-carboxamide
4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1?^{6},2-benzothiazine-3-carboxamide
4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide
4-Hydroxy-2-methyl-3-(2-pyridylcarbamoyl)-2H-1,2-benzothiazine 1,1-Dioxide
4-Hydroxy-2-methyl-3-(pyrid-2-yl-carbamoyl)-2H-1,2-benzothiazine 1,1-dioxide
4-Hydroxy-2-methyl-3[pyrid-2-yl-carbamoyl]-2H-1,2-benzothiazine 1,1-dioxide
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzo-thiazine-3-carboxamide1,1-dioxide
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid [German]
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide
4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
4-Hydroxy-2-methyl-N-(pyridin-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide
4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide1,1-dioxide
4-Hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
4-Hydroxy-3-(pyridin-2-yl-carbamoyl)-2-methyl-2H-1,2-benzothiazin-1,1-dioxide
A19556
AB00052074_23
AB00052074_24
AB00052074-21
AB00052074-22
AB0011706
AB2000240
AC-24190
AC1L1J3Z
AC1NQX1P
AC1NSM2R
AC1Q3XLJ
AJ-111664
AK1015
AK142892
AKOS000714958
AKOS025312555
AKOS026749939
Akten
AM84917
Ambap36322-90-4
ANW-43611
Apo-Piroxicam
Artroxicam
BAS 04381594
BAXO
BBL016493
BC204217
BCBcMAP01_000176
BCP0726000299
BDBM85245
BIDD:PXR0154
Bio-0759
Bio1_000363
Bio1_000852
Bio1_001341
Bio2_000355
Bio2_000835
BPBio1_000245
Brexidol (TN)
Brexin (TN)
BRN 0627692
Bruxicam
BSPBio_000221
BSPBio_001030
BSPBio_002460
C01608
C15H13N3O4S
Caliment
CAS_36322-90-4
CAS-36322-90-4
CCG-36403
CCRIS 3719
CHEBI:8249
CHEMBL1518938
CHEMBL527
CHF 1251
CP 16171
CP-16,171
CP-16171
CP16171
CS-2233
CTK7I2700
D00127
D00IBN
DB00554
DivK1c_000369
DR001567
DSSTox_CID_1170
DSSTox_GSID_21170
DSSTox_RID_75990
DTXSID5021170
EINECS 252-974-3
EN300-70724
Erazon
Erazon (TN)
EU-0100900
Exipan (TN)
F0001-2399
Felden
Felden (TN)
Feldene
Feldene (TN)
Feldene Fast
Feldene Gel
Feldene, Roxam, Piroxicam
Feldoral (TN)
Flogobene
FT-0080892
FT-0630590
Geldene
GTPL7273
HE168177
HE338394
HE418346
HMS1362D11
HMS1568L03
HMS1792D11
HMS1920H22
HMS1990D11
HMS2089B06
HMS2092A05
HMS2095L03
HMS2231G03
HMS3262D22
HMS3267I03
HMS3369B07
HMS3403D11
HMS3429L03
HMS3655C04
HMS501C11
Hotemin (TN)
HY-B0253
IDI1_000369
IDI1_002110
Improntal
J10253
KB-284635
KBio1_000369
KBio2_000370
KBio2_001595
KBio2_002938
KBio2_004163
KBio2_005506
KBio2_006731
KBio3_000719
KBio3_000720
KBio3_001680
KBioGR_000370
KBioGR_001315
KBioSS_000370
KBioSS_001595
KS-00000JBT
KS-5322
Larapam
Lopac-P-5654
Lopac0_000900
LP00900
LS-7663
M-9898
MCULE-1939282084
MFCD00057317
MLS000038002
MLS000069644
MLS001148207
MLS001304054
MLS004774122
Mobilis (TN)
MolPort-001-888-120
MolPort-035-874-705
N-(2-pyridyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
NCGC00015823-01
NCGC00015823-02
NCGC00015823-03
NCGC00015823-04
NCGC00015823-05
NCGC00015823-06
NCGC00015823-07
NCGC00015823-08
NCGC00015823-09
NCGC00015823-10
NCGC00015823-11
NCGC00015823-12
NCGC00015823-13
NCGC00015823-14
NCGC00015823-15
NCGC00015823-17
NCGC00015823-18
NCGC00021244-03
NCGC00021244-05
NCGC00021244-06
NCGC00021244-07
NCGC00021244-08
NCGC00021244-09
NCGC00188982-01
NCGC00257705-01
NCGC00261585-01
NCI60_022912
NINDS_000369
NSC 666076
NSC_4856
NSC-666076
NSC-757284
NSC666076
NSC757284
Opera_ID_442
Oprea1_714707
P 5654
P1905
Pharmakon1600-01500491
Pipoxicam
Pirkam
Piroflex
Piroftal
Pirox von ct (TN)
Piroxicam (Feldene)
Piroxicam (JP15/USP/INN)
Piroxicam (JP17/USP/INN)
Piroxicam [USAN:BAN:INN:JAN]
Piroxicam [USAN:USP:INN:BAN:JAN]
Piroxicam 1.0 mg/ml in Methanol
Piroxicam for system suitability
piroxicam usp
Piroxicam, >=98% (TLC)
Piroxicam, British Pharmacopoeia (BP) Reference Standard
Piroxicam, European Pharmacopoeia (EP) Reference Standard
Piroxicam, meets USP testing specifications
Piroxicam, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Piroxicam, United States Pharmacopeia (USP) Reference Standard
Piroxicamum
Piroxicamum [INN-Latin]
Prestwick_573
Prestwick0_000211
Prestwick1_000211
Prestwick2_000211
Prestwick3_000211
Proponol (TN)
Pyroxycam
QYSPLQLAKJAUJT-UHFFFAOYSA-N
Reudene
Reumador (TN)
Riacen
Rosiden
Roxam
Roxam;Feldene
Roxicam
Roxiden
s1713
Sasulen
SBI-0050875.P004
SC-16825
SCHEMBL13462
SCHEMBL21350
SCHEMBL3703617
SMR000035997
Solocalm
SPBio_001293
SPBio_002142
Spectrum_001115
SPECTRUM1500491
Spectrum2_001287
Spectrum3_000780
Spectrum4_000968
Spectrum5_001445
ST069379
ST2411449
STK177288
Tocris-0960
Tox21_110231
Tox21_110231_1
Tox21_200151
Tox21_500900
TR-014899
Tracam (TN)
UNII-13T4O6VMAM
Veral (TN)
Vurdon (TN)
W-106626
Z1259192069
ZINC12466469
ZINC51133897
ZINC87724780
Zunden

US Patents and Regulatory Information for piroxicam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pii PIROXICAM piroxicam CAPSULE;ORAL 206136-001 Jun 20, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Scs PIROXICAM piroxicam CAPSULE;ORAL 074036-001 May 29, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cycle Pharms Ltd PIROXICAM piroxicam CAPSULE;ORAL 073651-001 Feb 26, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Ireland Ltd PIROXICAM piroxicam CAPSULE;ORAL 074118-001 Jun 15, 1993 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Micro Labs PIROXICAM piroxicam CAPSULE;ORAL 206152-001 Dec 29, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Breckenridge Pharm PIROXICAM piroxicam CAPSULE;ORAL 208991-001 Feb 21, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva PIROXICAM piroxicam CAPSULE;ORAL 074131-002 Dec 11, 1992 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for piroxicam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-003 Apr 6, 1982 ➤ Sign Up ➤ Sign Up
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-003 Apr 6, 1982 ➤ Sign Up ➤ Sign Up
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982 ➤ Sign Up ➤ Sign Up
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982 ➤ Sign Up ➤ Sign Up
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982 ➤ Sign Up ➤ Sign Up
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982 ➤ Sign Up ➤ Sign Up
Pfizer FELDENE piroxicam CAPSULE;ORAL 018147-002 Apr 6, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Dow
Johnson and Johnson
Teva
Harvard Business School
Boehringer Ingelheim
QuintilesIMS
Medtronic
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.